Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biktarvy
Biktarvy
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
JNJ
GSK
ViiV
Gilead Sciences
HIV
Cabenuva
Biktarvy
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Yahoo/Reuters
Fri, 02/24/23 - 09:08 am
GSK
HIV
ViiV Healthcare
Gilead Sciences
Cabenuva
Biktarvy
Gilead reports 'very strong quarter' despite slipping Veklury sales
Endpoints
Wed, 08/3/22 - 10:55 am
Gilead Sciences
earnings
Biktarvy
GSK to get $1.25 bln to settle HIV drug patent row with Gilead
Reuters
Wed, 02/2/22 - 11:01 am
GSK
Gilead Sciences
HIV
Biktarvy
patents
Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness
NASDAQ
Fri, 10/29/21 - 11:05 am
Gilead Sciences
Biktarvy
HIV
RWE
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Mon, 03/8/21 - 11:04 am
Gilead Sciences
Biktarvy
HIV
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Pharmaceutical Business Review
Thu, 10/22/20 - 11:04 am
Gilead Sciences
Biktarvy
HIV
GSK's plan to take over the HIV drug market hasn't worked out
BioPharma Dive
Mon, 01/6/20 - 11:47 pm
GSK
FDA
HIV
Dovato
Biktarvy
ViiV Healthcare
Gilead Sciences
Will Its HIV Lineup Save Gilead Sciences?
Motley Fool
Mon, 11/11/19 - 07:50 pm
Gilead Sciences
HIV
Descovy
Biktarvy
Gilead Sciences Reports Improving Revenue in the 2nd Quarter
Motley Fool
Wed, 07/31/19 - 08:47 am
Gilead Sciences
earnings
Biktarvy
Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void
Fierce Pharma
Thu, 07/11/19 - 09:45 am
AbbVie
Humira
Gilead Sciences
Biktarvy
Truvada
Pfizer
Xeljanz
television ads
DTC ads
Gilead Sciences’ Biktarvy shows high efficacy in HIV-1 study
Pharmaceutical Business Review
Thu, 10/4/18 - 09:42 am
Gilead Sciences
Biktarvy
HIV-1
HIV
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
Mon, 07/16/18 - 09:21 am
HIV
Gilead Sciences
Biktarvy
GSK
Triumeq
Genvoya
Tivicay
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Yahoo/Reuters
Wed, 06/20/18 - 09:28 am
GSK
Gilead Sciences
HIV
AIDS
Dolutegravir
lamivudine
Biktarvy
GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth
Fierce Pharma
Sat, 04/28/18 - 12:13 pm
GSK
HIV
Biktarvy
Gilead Sciences
Triumeq
Tivicay
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
CP Wire
Fri, 04/27/18 - 11:39 am
Gilead Sciences
Biktarvy
HIV
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
Fri, 04/27/18 - 09:56 am
Gilead Sciences
Biktarvy
HIV
Gilead: Did Biktarvy Kill The Sell Thesis?
Seeking Alpha
Tue, 03/27/18 - 09:54 am
Gilead Sciences
Biktarvy
HIV
Kite Pharma
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
Mon, 03/26/18 - 10:45 am
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Pages
1
2
next ›
last »